Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | Journal of Translational Medicine

Fig. 4

From: Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients

Fig. 4

Kaplan–Meier survival curves for overall survival according to FGFR1, FGFR2, FGFR3, and FGFR4. a Cervical cancer patients with high FGFR2, FGFR3, and FGFR4 expression had longer overall survival (P = 0.003, P = 0.002, and P = 0.003, respectively) than those with low expression. b The combination of FGFR2, FGFR3, and FGFR4 was found to enhance prognostic accuracy for cervical cancer. The patients with FGFR2+/FGFR3+/FGFR4+ expression had significantly longer overall survival (P < 0.001) than those with FGFR2-/FGFR3-/FGFR4- expression. P values were obtained from log-rank tests

Back to article page